Raltegravir Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo

• Main Authors: Xue Zhang (Author), Haidi Huang (Author), Guanghua Zhang (Author), Defang Li (Author), Hongbo Wang (Author), Wanglin Jiang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Raltegravir, an inhibitor of human immunodeficiency virus-1 (HIV-1) integrase, has been used to treat HIV/acquired immunodeficiency syndrome; however, its therapeutic effects on pulmonary fibrosis have not been investigated. In this study, the in vitro effects of raltegravir (RAV) on transforming gr...